Treace Medical Concepts, Inc.
TMCI
$6.72
-$0.26-3.73%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -23.49% | 52.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.49% | 52.39% | |||
| Cost of Revenue | -19.30% | 47.77% | |||
| Gross Profit | -24.49% | 53.54% | |||
| SG&A Expenses | 2.86% | 9.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.03% | 14.35% | |||
| Operating Income | -10,219.21% | 99.00% | |||
| Income Before Tax | -3,078.04% | 96.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,078.04% | 96.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,078.04% | 96.74% | |||
| EBIT | -10,219.21% | 99.00% | |||
| EBITDA | -1,308.20% | 108.37% | |||
| EPS Basic | -3,076.25% | 96.76% | |||
| Normalized Basic EPS | -3,428.89% | 97.08% | |||
| EPS Diluted | -2,297.17% | 95.71% | |||
| Normalized Diluted EPS | -3,428.89% | 97.08% | |||
| Average Basic Shares Outstanding | 0.51% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.51% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||